Marketresearchnews

Saturday, 12 December 2020

Eye Cancer Market Swot Analysis, Major Key Players Revenue, Analysis And Forecasts To 2023

Market Highlights

Although the prevalence of this disease is considered rare. Porphyria is a disorder that occurs when there is a build-up of the chemicals in the body that produce a substance called porphyrin. Acute intermittent porphyria (AIP) is a genetic metabolic disorder is one of the 8 types of porphyria. It affects the production of heme, the oxygen-binding prosthetic group of hemoglobin. Children have a 50% chance of inheriting any of the 8 different types of porphyria if their parents have the disorder.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4736

Market Highlights

Eye cancers or ocular cancers manifests itself in the eye. Cancer is referred to the uncontrolled growth of the cells, similarly, eye cancer occurs when healthy cells in or around the eye change and grow uncontrollably leading to the formation of tumors. The global eye cancer market is expecting a healthy growth in coming future. The global market is majorly driven by increasing eye cancer patients across the globe. Additionally, increasing smoking population and rising consumption of alcohol have spurred the growth of the market. However, long time for approval, and side effects of the treatment may hinder the growth of the market.

The global eye cancer market is expected to grow at a CAGR of 8.3% during the forecast period 2017-2023.

Segmentation

The global market is segmented on types, treatment and end users. On the basis of types, the market is segmented into intraocular cancer, squamous cell cancer, rhabdomyosarcoma, and others. Intraocular cancer is further segmented into melanoma of the eye, lymphoma of the eye, and cancers in children. On the basis of treatment, the market is categorised into chemotherapy, surgery & radiation therapy, targeted therapy, hormone therapy, biologic therapy, and other. Chemotherapy is further segmented into anthracyclines, taxanes, antimetabolites, and alkylating agents. Target therapy is sub segmented into monoclonal antibodies and tyrosine kinase inhibitors. Hormone therapy is further segmented into selective estrogen-receptor modulators (SERMs), aromatase inhibitors and others. On the basis of end users, the market is segmented into hospital & clinics, ambulatory care centers and others.

Regional Analysis

The Americas dominate the global market owing to a huge patient population, large geriatric population, high healthcare spending and strong government support for research & development. As per the report of the Centers for Disease Control and Prevention, in 2014, over 14.1 million of new cancer cases were registered worldwide. Increasing prevalence of the disease has boosted the market growth in America. Additionally, changing lifestyle and smoking has fuelled the growth of the market.

Europe holds the second leading market in global eye cancer market which is followed by Asia Pacific. Asia Pacific is the fastest growing market for eye cancer. Asia Pacific eye cancer market is majorly driven by Japan, India, and China owing to a huge patient pool, and rapidly developing healthcare sector. The Middle East and Africa contribute the least to the growth of global market. The Middle East dominates the market for The Middle East and Africa. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East eye cancer market. However, Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition of the region. However the growth of the Africa market is high due to the presence of opportunities for the development of the market.

Key Players

Some of key the players in the market are Novartis AG (Switzerland), Spectrum Pharmaceuticals Inc. (U.S.), GlaxoSmithKline Plc. (U.K.), Bayer AG (Germany), Amgen, Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Eli Lilly and Company (U.S.), AstraZeneca Plc. (U.K), F. Hoffmann-La Roche Ltd. (Switzerland), Janssen Biotech, Inc. (U.S.), Sanofi (France), AbbVie Inc. (U.S.), Takeda Pharmaceuticals (Japan), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), Oncomed Pharmaceuticals (U.S.) and Immunomedics (U.S.).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/eye-cancer-market-4736

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Acute Intermittent Porphyria Market Solid Segment Analyzed By Latest Trends, Growth Rate And 2023 Insight

Market Highlights

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4713

Increasing prevalence of rare diseases, rising demand for better treatment, increasing investment in biotechnology and pharmaceutical industries for R&D, and availability of funds drive the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapidly developing technology is expected to fuel the market growth during the forecast period. However, high cost of the treatment may slow the market growth during the period 2017-2023.

The global acute intermittent porphyria market is expected to grow at a CAGR of 5.6 % during the forecast period 2017-2023.

Regional Analysis

The Americas dominate the global acute intermittent porphyria market owing to the presence of huge patient population with gastrointestinal problems, neurological issues, high healthcare spending, and increasing government support for research & development.

Europe holds the second largest share of the global acute intermittent porphyria market as result of increasing focus of various government agencies on the treatment of rare diseases such as acquired aplastic anemia. Moreover, the growing public awareness about acquired aplastic anemia likely to boost the Europe market.

Asia Pacific is the fastest growing acute intermittent porphyria market across the globe. Japan holds the major share of the regional market due to availability of advanced technology and huge healthcare spending. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development projected to drive the market in China and India over the forecasted period.

The Middle East and Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.

Segmentation

The global acute intermittent porphyria market is segmented on the basis by diagnosis, by treatment, and by end user. On the basis of diagnosis, it is segmented into blood test, urine test, serum test, DNA test, and others. On the basis of treatment, it is segmented into gonadotropin-releasing hormone analogues, prophylactic hematin infusions, and others. On the basis of end user, it is segmented into hospitals & clinics, research centers, and others.

Key Players

Some of key the players in the market are Dahaner (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Siemens AG (U.S.), ARKRAY, Inc. (Japan), Sysmex Corporation (Japan), and ACON Laboratories, Inc. (U.S.).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/acute-intermittent-porphyria-market-4713

About Market Research Future:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Spinal Traction Market 2020 – Leading Manufactures, Regions, Drivers, Analysis And Forecasts Till 2023

Market Synopsis

According to a new report by Market Research Future (MRFR), the global spinal traction market is expected to reach USD 6.0 billion by the end of 2023. The market is envisaged to witness a steady growth to expand at 7.7 % CAGR over the forecast period (2017-2023) owing to the growing geriatric population. Spinal traction devices are used to stabilize and decompress the spine for treating several spinal disorders and orthopedic conditions like bone fractures, muscle contracture, and bone deformities like kyphosis, scoliosis, and lordosis. These devices are also used in treating low back pain and muscle spasms. Spinal traction devices are also used to prepare patients for surgical procedures like interbody fixation, endoscopic spine surgery, vertebral compression fracture repair, and interspinous fixation.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1902

Future Drivers and Constraints

Increasing production number of spinal surgery, implants, and ongoing researches for improving the quality of care are expected to create attractive growth opportunities for the market globally. With the increasing cases of trauma and spinal cord diseases, growing geriatric population, increase in the number of spinal surgeries, screening and awareness, and developing healthcare are some of the factors propelling the market growth over the review period.

Also, the shift in the preference among patients and surgeons for adopting minimally invasive (MI) surgery over traditional surgeries have resulted in the development of advanced spinal implants. The rising number of clinical trials of latest technology implants is also propelling the market growth over the assessment period.

Innovation has remained the best strategy with companies focusing on developing new devices which can offer better treatment and diagnostic to various types of spine conditions. Wireless sensor technology is one of the latest researches with advanced products connected to external devices for analysis and healing progress.

Meanwhile, costly devices, lack of experimental clinical data in medical treatment, risk related after surgery which comprises risk of damage and infection to the spine, and demand for minimally invasive procedures is assessed to hamper the growth of the market over the forecast period.

Global Spinal Traction Market Segmentation

The global market for spinal traction has been segmented on the basis of diagnosis, type, treatment, end-users, and region.

The market has been segmented into mechanical spinal traction and manual spinal traction based on types. The market has been segmented into herniated discs, sciatica, facet disease, slipped discs, bone spurs, foraminal stenosis, pinched nerves, and degenerative disc disease, based on applications. The market has been segmented into gravity-dependent traction, manual traction, and continuous traction based on devices.

The market has also been segmented into academic and research, hospitals and clinics, and others based on end-users. Among these, the segment for hospital dominated the global market for spinal traction and is predicted to maintain its dominance over the assessment period.

Regional Analysis

Geographically, the market for spinal traction has been spanned across regions such as North America, the Middle East and Africa, Europe, and Asia Pacific.

The North American region is anticipated to hold the largest market share due to the high expenditure on healthcare. Also, adoption of medical devices and new diagnostics in the U.S. is also expected to drive the market in this region. Moreover, the presence of large hospital networks and major healthcare companies in the developed countries is propelling the market growth over the assessment period.

Europe holds the second largest position after North America, owing to the penetration of strong healthcare and high income in this region. Countries such as France and Germany are expected to lead the market growth in the European region. The UK is anticipated to emerge as the fastest growing market over the review period due to the presence of strong pharmaceutical industry.

Asia Pacific is estimated to grow rapidly over the assessment period. India and China are likely to lead the market owing to the huge unmet requirement and fast-growing healthcare sector over the assessment period. Moreover, South East Asian countries like India, China, and Malaysia are estimated to contribute to the market growth. Also, increasing penetration of healthcare insurance in the Asia Pacific region is anticipated to spur the market growth in this region.

Moreover, the UAE and Saudi Arabia are anticipated to drive the Middle East and African market. The African region is expected to witness moderate growth due to poor political and economic conditions.

Industry News

Natural compounds derived from Australian plants have been found to stimulate cells and are useful for transplantation to repair injuries in the spinal cord. The results have been published in the Scientific Reports by a team of scientists recently at the Menzies Health Institute Queensland and Griffith Institute for Drug Discovery.

Competition Analysis

The prominent players operating the spinal traction market are Stoll Medizintechnik GmbH, Spinal Designs International Inc., Saunders Group Inc., SpineRx Technology, VAX-D Medical Technologies LLC., Scrip, Inc. BTL, North American Medical (NAM) Corporation, Spinetronics, LLC, Dentsply International, Medtronic Inc., CERT Health Sciences LLC, Hill Laboratories Company, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/spinal-traction-market-1902

About Market Research Future:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Dental consumables Industry Growth, Trends And Forecast Till 2023 By Marketresearchfuture.Com

North America Dental Consumables Market- Overview

The North America Dental Consumables Market is growing with a rapid pace. According to a recent study report published by the Market Research Future, the North America Dental Consumables Market is booming and expected to gain prominence over the forecast period and is projected to grow a sound pace. The market is projected to demonstrate a sound growth by 2023, surpassing its previous growth records in terms of value with a sound CAGR during the anticipated period (2017-2023).

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4612

Dental Consumables are a category of products that are used on patients by dental practioners or dentists in order to treat and /or perform procedures associated with preventive, restorative, diagnostic and emergency oral health issues. Factors such as increasing prevalence of dental diseases and rising number of dental procedures are the major drivers for the market growth. According to the American Dental Association, in 2014, 52.3% of adults reported to visit the dentist in every six months, 15.4% reported once per year, and 11.0% reported once every two to three years. Moreover, according to the Centres for Disease Control and Prevention, in 2014, 19% of the children aged 5-19 years and 31% of adults aged 20-44 have untreated dental caries. Additionally, growing geriatric population is fuelling the market growth. However, poor reimbursement policies and gray market of dental distribution are estimated to restrain the market growth during the forecast period. According to the National Coalition on Health Care, in 2012, American families spent an average of USD 9,000 on out-of-pocket health insurance and other medical costs like co-pays and deductibles.

North America Dental Consumables Market- Competitive Analysis

Institut Straumann AG, Henry Schein, Inc., Patterson Dental Supply, Inc., Dentsply Sirona, Kerr Corporation, Danaher Corporation, GC orthodontics, Planmeca Oy, and American Orthodontics, and others are some of the prominent players at the forefront of competition in the North America Dental Consumables Market and are profiled in MRFR Analysis.

Characterized by the presence of several well-established and small players, the North America Dental Consumables Market appears to be highly competitive and fragmented. International players are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers.

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

In August, 2016- Henry Schein announced that it will acquire 80% ownership of Marrodent, which is a full service dental distributer of Poland, thus marking Henry Schein’s entry into the dental market of Poland.

In July, 2016- Kitron signs supply agreement with Dentsply Sirona. This agreement will add Kitron as a new supplier for Dentsply Sirona.

In April, 16- Straumann acquired 51% residual ownership of Neodent. This deal augments Straumann’s presence in the tooth replacement sector in the Latin American region and Brazil, which is the second largest market for implant dentistry.

In February, 16- Septodont signed an agreement with Egalet Corporation, a specialty pharmaceutical company, for exclusive marketing rights to promote Sprix nasal spray to the dental market in the United States.

In May, 16- Knifeless Tech Systems was acquired by 3M. The business acquired is an installation tool used to cut self-adhesive films applied to vehicle wraps.

In February, 16- Septodont acquired DLA, an injectable dental anaesthetic manufacturing plant from Dentsply International.

In February, 16- DENTSPLY International Inc. and Sirona Dental Systems, Inc. Announce Completion of Remaining Regulatory Milestones for Proposed Merger.

North America Dental Consumables Market- regional analysis

Regionally, North America is divided into the U.S. and Canada. The U.S. is estimated to lead the North America Dental Consumables Market owing to high expenditure on the health care within the region. Moreover, the fastest uptake of new products in the U.S drives the dental consumables market. Additionally, concentration of the major healthcare companies in the developed economies of this region coupled with large insurance penetration is also adding fuel to the market growth.

FOR MORE DETAILS –https://www.marketresearchfuture.com/reports/north-america-dental-consumables-market-4612

About Market Research Future:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Friday, 11 December 2020

EMEA Blood Glucose Test Strip Packaging Market Top 10 Players Universal Analysis, Industry Demand And 2023 Forecast

Market Highlights

In the end, the report introduced medical suction device market SWOT analysis, PEST analysis, market share analysis and competitive landscape, company profiles by analyzing the major players. It is a depth research study on Europe, the Middle East and Africa Blood Glucose Test Strip Packaging Market. We are thankful for the support and assistance from Europe, the Middle East and Africa Blood Glucose Test Strip Packaging Market chain related technical experts and marketing experts during Research Team survey and interviews.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/601

Table Of Contents

1 Introduction

1.1 Definition

1.2 Scope Of The Study

1.2.1 Research Objectives

1.2.2 Assumptions & Limitations

1.3 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

2.4 Forecast Model

3 Report Excerpt

4 Forecast Indicators

4.1 Introduction

4.2 Growth Drivers

4.3 Growth Barriers

4.4 Growth Opportunities

4.5 Macroecnomical Indicators

5 Market Analysis

6 Europe, The Middle East And Africa Blood Glucose Test Strip Market

6.1 Introduction

6.2 By Volume

6.3 By Value

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/europe-blood-glucose-test-strip-packaging-market-601

About Market Research Future:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Point of Care Technology Market Swot Analysis, Major Key Players Revenue, Analysis And Forecasts To 2023

Market Highlights

Point of care technology is termed as a time when clinicians deliver healthcare products and services to patients. Point of care technology includes diagnostics, devices for documentation, and others. Point of care documentation devices smooth the workflow, reduces errors in a clinical tasks including diagnostics, medication prescribing, and medication administration, which will indirectly boost the growth of the market. Moreover, increasing prevalence of the diseases and rising research and development facilities. Furthermore, rising healthcare expenditure, and increasing awareness among the people regarding the point of care diagnostics products, are some of the factors that are expected to fuel the market growth. On the other hand, higher cost of the point of care technology is may affect the growth of the market negatively during the forecasted period. Moreover, development in the diagnosis of patients with chronic diseases, for instance, diabetes, and growing medical technology are likely to increase the growth of the market. In point of care technology, it provides ease of diagnosis where the patient is seen at home. The point of care testing devices in the healthcare focuses on quality rather than test volume, which is expected to boost the growth of the market over the review period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1164

Complexity of documentation in the point of care technology may hinder the growth of the market during the forecasted period.

The global point of care technology market is expected to grow at a CAGR of 9.5% during the forecast period 2017–2023.

Taste the market data and market information presented through more than 105 market data tables and figures spread over 100 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “point of care technology market research report–Global forecast till 2023.”

Major Players in Point of care technology Market

Some of the key players in the global market are Abbott (U.S.), Johnson & Johnson Services, Inc.(U.S.), Techno MedicaCo., Ltd. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Siemens AG (Germany), Alere Inc. (U.S.), Instrumentation Laboratory (U.S.), PTS Diagnostics (U.S.), Nova Biomedical (U.S.), Beckman Coulter, Inc. (U.S.) BD (U.S.), Quidel Corporation (U.S), Meridian Bioscience, Inc. (U.S).

Regional Analysis

The global point of care technology market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas accounts for a significant share of the global point of care technology market as a result of the presence of huge & increasing patient population base and the largest producer and consumer of medical devices. Similarly, the demand for medical devices in Europe is expected to increase growth of the market positively. Europe holds the second position in the global market, which is followed by Asia Pacific. Asia Pacific may experience the growth owing to the presence of abundant opportunities for medical device manufacturers. For instance, healthcare services revenue is increasing rapidly, especially, in India and China, which is predicated to result in a large number of new hospital construction projects.

Whereas, the Middle East & Africa holds the least share in the global point of care technology market on account of poor economic condition and less development in healthcare infrastructure.

Segmentation

The global point of care technology is segmented by type of products, and end users. On the basis of type of product, it is segmented into glucose testing, cardiac markers, HbA1c testing, and coagulation, and others. On the basis of end users, it is segmented into clinics, hospital, home care, ambulatory care, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/point-of-care-technology-market-1164

About Market Research Future:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Worldwide High Intensity Focused Ultrasound (HIFU) Market 2020 Synopsis With Leading Players, Industry Growth Factor Foresight By 2023

Market Highlights

High-intensity focused ultrasound (HIFU) therapy is a novel, emerging, and therapeutic modality technology. It involves propagation of ultrasound waves through cancerous tissues that kills cancer cells. HIFU is a minimal invasive technique and is performed with real-time imaging by ultrasound or MRI to enable treatment targeting and monitoring. This technology have been extensively exploited for the treatment of prostate, liver, pancreatic, and bladder cancer. The American Cancer Society estimated that about 161,360 new cases of prostate cancer have been registered in the US in 2017. Moreover, the number of people living beyond a cancer diagnosis were nearly 14.5 million in 2014 and is expected to rise to over 19 million by 2024. Moreover, increasing development in the medical technology and its wide range of application used in the treatment of uterine fibroids, neurological disorders, cosmetic medicine and others fuel the growth of this market. However, high cost of the treatment and certain adverse effects are likely to restrain the market growth over the forecasted period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/885

The global high intensity focused ultrasound (HIFU) therapy market is expected to grow at a CAGR of 7.8% during the forecast period 2017–2023.

Taste the market data and market information presented through more than 115 market data tables and figures spread over 110 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “high intensity focused ultrasound (HIFU) therapy market research report–Global forecast till 2023.”

Major Players in High intensity focused ultrasound (HIFU) therapy Market

Some of the key players in the global market are Image Guided Therapy, EDAP TMS, SonaCare Medical, LLC, Theraclion, Chongqing Haifu Medical Technology Co., Ltd, Koninklijke Philips N.V., Shanghai A&S Co. LTD, Mianyang Sonic Electronic Ltd., Insightec, Alpinion Medical Systems, and FUS Instruments.

Regional Analysis

The global high intensity focused ultrasound (HIFU) therapy market consists of four regions including the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominates the global HIFU therapy market. North America is the largest market owing to rising prevalence of cancer cases in the American counties and well-developed technology in this region contributes majorly to the growth of this market.

Europe accounts for the second largest share of the global HIFU therapy market. In the Europe, wide demand for cancer diseases treatment methods drives the market growth. Moreover, increasing expenditure in the healthcare domain and investment in research & development in developing new treatment methods for cancer diseases will fuel to the growth of this market.

Asia Pacific is the fastest growing market in the world. India is the largest potential market due to increasing investments in healthcare services and increasing adaption of new technologies used for diagnosis and treatment methods.

The Middle East & Africa is expected to witness a steady growth due to rising demand for primary healthcare services such as new and advanced treatment methods in healthcare domain.

Segmentation

The global high intensity focused ultrasound (HIFU) therapy market has been segmented on the basis of modality, which comprises of therapeutic ultrasound, hemostasis, lithotripsy, thrombolysis, immunomodulation, and others. On the basis of the methods, the market is segmented into non-invasive method and minimal invasive method. On the basis of applications, the market has been segmented into prostate cancer, uterine fibroids, neurological disorders, cosmetic medicine, and others. On the basis of end users, the market has been segmented into diagnostic centers, hospitals, research centers, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/high-intensity-focused-ultrasound-therapy-market-885

About Market Research Future:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com